Milestone Scientific Narrows Q1 Loss, Reaffirms 2026 Outlook as CompuFlo Momentum Builds

Overview

• Milestone Scientific reported Q1 2026 revenue of about $2.16 million, an operating loss of $828,000, and a net loss of $840,000 after cutting operating expenses by roughly 30% year over year.
• Management kept full‑year 2026 revenue guidance at $9.8 million to $10.2 million and said it still targets cash‑flow breakeven in early 2027.
• Medical traction improved as CompuFlo sales more than doubled year over year, the advisor program grew to more than ten physician partners, and the company set a June meeting with First Coast to advance Medicare coverage with a Category I submission planned for November.
• After the quarter ended on April 20, 2026, the company raised about $2.15 million in a private placement to support sales expansion, inventory, and digital marketing.
• Revenue was held back by roughly $200,000 in orders delayed by Middle East shipping disruptions, and management said most of those units have now shipped in Q2.